Previous 10 | Next 10 |
home / stock / fsnuf / fsnuf news
This month I added capital to 7 of my holdings. Dividends were up $19.17 YoY. My forward dividend yield at the end of April was approximately $927. For further details see: My Portfolio April Update - 7 Buys
Fresenius SE & Co. KGaA (FSNUF) Q1 2022 Earnings Conference Call May 4, 2022, 7:30 AM ET Company Participants Stephan Sturm – President & Chief Executive Officer Rachel Empey – Chief Financial Officer Markus Georgi – Head of Investor Relations Conference Call Part...
Fresenius SE & Co. KGaA press release (OTCPK:FSNUF): Q1 GAAP EPS of €0.83. Revenue of €9.72B (+8.2% Y/Y) misses by €230M. For further details see: Fresenius SE & Co. KGaA GAAP EPS of €0.83, revenue of €9.72B misses by €230M...
ABC,AMRN,AMRX,ASC,ATI,AVA,AVNS,BDC,BIP,BLX,BRKR,BRY,BWA,CDW,CFMS,CGAU,CLDT,CLH,CLVS,CMLS,CRL,CRTO,CSII,CVS,DCPH,DIN,DOC,OTCPK:EADSF,EAT,EDIT,EMR,OTCPK:ENLAY,EXPI,EYPT,FDP,FMS,OTCPK:FSNUF,FTS,FUN,GEL,GNRC,GOLD,GTHX,HZNP,IDXX,IMKTA,INSW,IONS,ISEE,JCI,JHG,OTCPK:LBLCF,LITE,LL,LNG,MAR,MCRB,MFA,MIR...
Fresenius is an interesting investment - certainly in part because it doesn't require an ADR, you can invest in the medical care wing with the symbol FMS. The company's organic growth has been slowed down, and the recovery for the company is likely in the future - but the upside is no...
Fresenius is a diversified healthcare company. The company pays out a growing dividend. A potential break-up and the reduced effect of Covid could act as tailwinds for the company. For further details see: Fresenius: Undervalued Healthcare Giant
This month I had a total of 6 transactions, of which 5 were buys and 1 was a sell. Dividends received hit a new high. My new forward dividend yield is $914.31 after-tax. For further details see: My Portfolio March Update - 5 Buys And 1 Sale
The war in Ukraine continues to dominate market movements. I am not selling anything and predominantly focus on adding dividend income via select purchases. The combination of soaring inflation and geopolitical uncertainty has rattled markets but despite some dramatic movements, s...
The European Commission granted marketing authorization to Fresenius' (OTCPK:FSNUF) (OTCPK:FSNUY) Kabi's Stimufend (pegfilgrastim), a biosimilar to Amgen's (AMGN) Neulasta. The approval was for all indications of the reference product. The company said Stimufend stimulates the growt...
Fresenius' (OTCPK:FSNUF) (OTCPK:FSNUY) Kabi said it is acquiring a 55% stake in Spain's Insud Pharma's mAbxience division to bolster its biosimilars pipeline. The purchase price will be combination of €495M upfront and milestone payments tied to achieving commercial and devel...
News, Short Squeeze, Breakout and More Instantly...
Fresenius SE & Co KGaA Company Name:
FSNUF Stock Symbol:
OTCMKTS Market:
Fresenius SE & Co KGaA Website:
NEW YORK , Nov. 6, 2019 /PRNewswire/ -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on November 13 th and 14 th , featuring live webcast presentations from international companies with American Depositary Receipt (ADR) prog...